ArticleVeterinary medicine and science2026
Dietary Spirulina Ameliorates Arsenic-Induced Toxicity in Nile Tilapia, Oreochromis niloticus.
Article in Veterinary medicine and science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Dietary Spirulina Ameliorates Arsenic-Induced Toxicity in Nile Tilapia, Oreochromis niloticus.Veterinary medicine and science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Arsenic (As) contamination in aquaculture systems poses a serious threat to fish health, food safety and sustainable production, yet effective nutritional strategies to mitigate its toxicity remain limited. This study evaluates the protective role of dietary spirulina against As-induced physiological and biochemical disturbances in Nile tilapia (Oreochromis niloticus). In this study, the Nile tilapia O. niloticus (0.65 ± 0.04 g) were exposed to As with or without spirulina, representing control (no spirulina and As); T1, (spirulina 0 g/kg and As 5 mg/kg); T2 (spirulina 0 g/kg and As 10 mg/kg); T3 (20 g/kg of spirulina and As 5 mg/kg); and T4 (20 g/kg of spirulina and As 10 mg/kg) for 56 days. At the completion of the feeding trial, fish were analysed for growth, feed performance and haematological traits. A significant decrease (p < 0.05) in weight gain (WG) and specific growth rate (SGR) was observed with increasing dietary As levels when compared to the control group. However, dietary spirulina improved the negative effects on fish growth. Similarly, lower feed utilization observed in the fish fed non-spirulina As supplemented diet in comparison to spirulina supplemented diet. Haemoglobin (Hb) content significantly (p < 0.05) lowered with the increase of As level in non-spirulina supplemented fish, however dietary spirulina improved the Hb level. On the other hand, opposite trend noticed in term of blood glucose levels. Moreover, dietary spirulina supplementation significantly lowered the As accumulation in fish muscle in comparison to non-spirulina supplemented group. The results of this study indicate that spirulina has a notable capacity to counteract the toxic effects of As in Nile tilapia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.